No Data
No Data
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
Mustang Bio Announces Closing of $8 Million Public Offering
10-Q: Q3 2024 Earnings Report
8-K: Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements